“AROUND three-quarters of people living with arthritis believe their pain is affected by the weather,” explains Prof Will Dixon…

Barcelona, a city with undisputed character, ambience, and beauty, played host this year to the prestigious annual European Society…

Adoptive transfer of T cell receptor (TCR)-redirected T cells has been reported to exhibit efficacy in some patients with melanoma and sarcoma…

With a sustained number of new drugs or combination drugs entering standard of care this year, molecular testing should be…

Despite the impressive advances that have been made in cancer diagnosis and therapy, there still exist groups of patients who are not responding to standard anticancer treatments…

Patients with metastatic soft tissue sarcoma (STS) have a poor prognosis with a median survival of 12–14 months.1 First-line therapy consists…

As exciting and momentous as the progression in medical oncology continues to be, a different type of progression is still sorely needed across…

Mismatch repair-deficient (MMR-D) tumours exemplify the prototypic hypermutator phenotype. Owing to the high mutation rates, many neo-antigens…

Epithelial myoepithelial carcinoma (EMC) was initially described by Donath et al…

Although immunotherapy is better tolerated globally than chemotherapy, immune checkpoint inhibitors may be associated with immune-related…